The newer, 3D form of breast screening, known as digital breast tomosynthesis (DBT), is more effective at detecting breast cancer than traditional 2D digital mammography (DM). That's the conclusion of ...
Kian Gould, Founder and Chairman at Omnevo, Mikos Taylor, Chief Technology Officer at Harding, and Vijay Talwar, Chief ...
New Haven, Conn. — The newer, 3D form of breast screening, known as digital breast tomosynthesis (DBT), is more effective at detecting breast cancer than traditional 2D digital mammography (DM).
Aug 19 (Reuters) - Medifron DBT Co., Ltd. : * Says 1.5 billion won worth of its sixth convertible bonds have been converted into 476,190 shares of the company at 3,150 won per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback